vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
14.85
+0.82 (5.84%)
Aug 14, 2025, 11:52 AM - Market open

vTv Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1069123546798
Upgrade
Market Cap Growth
-12.62%288.02%-56.62%-18.92%-32.00%40.81%
Upgrade
Enterprise Value
8052276493144
Upgrade
Last Close Price
14.0313.8111.5026.5139.8074.40
Upgrade
PS Ratio
6237.9089.38-26.7616.6315.27
Upgrade
PB Ratio
13.296.36-1.269.254.3825.82
Upgrade
P/TBV Ratio
38.397.45----
Upgrade
EV/Sales Ratio
4717.7251.49-31.6923.2022.52
Upgrade
Debt / Equity Ratio
0.030.01-0.030.120.060.24
Upgrade
Asset Turnover
00.04-0.070.200.53
Upgrade
Quick Ratio
4.907.100.911.601.610.98
Upgrade
Current Ratio
4.987.341.003.521.841.13
Upgrade
Return on Equity (ROE)
-209.04%---238.10%-186.50%-
Upgrade
Return on Assets (ROA)
-43.93%-61.33%-72.03%-47.99%-62.28%-61.59%
Upgrade
Return on Capital (ROIC)
-138.19%---124.07%-120.21%-496.98%
Upgrade
Earnings Yield
-18.44%-20.31%-86.44%-35.48%-19.50%-8.68%
Upgrade
FCF Yield
-20.77%-27.84%-81.45%-29.70%-28.99%-18.38%
Upgrade
Buyback Yield / Dilution
59.13%-176.79%-8.60%-22.58%-32.90%-55.61%
Upgrade
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q